|Adjunctive medroxyprogesterone acetate to radical nephrectomy in category M0 renal cell carcinoma. Preliminary report of a prospective randomized trial.|
|PMID: 6223819 Owner: NLM Status: MEDLINE|
|From July 1979 to December 1981, 83 patients from 6 centers in the Lombardy underwent radical nephrectomy for category M0 renal cell carcinoma. Postoperatively they were randomly allocated to adjunctive medroxyprogesterone acetate (MPA) or to a control group. After the first year of follow-up, the relapse rate was 13% in the controls (5 of 38 evaluable patients) versus 28% in the MPA treatment group (9 of 32). Sex steroid receptors were studied in both the tumor and in the surrounding healthy parenchyma by the dextran-coated charcoal technique in 52 of 70 clinically evaluable patients. There was no significant correlation between receptor studies and the relapse rate. Besides, receptors were more often detected in the healthy than in the neoplastic tissue, and values rarely exceeded 10 fmol/mg protein. Due to the negative trend in the MPA treatment group, the admittance of patients to this study was stopped after 120 patients had been accepted.|
|G Pizzocaro; G Di Fronzo; L Piva; R Salvioni; E Ronchi; V Cappelletti; A Giongo; E Mastroberardino; C Cozzoli; E Dormia; S Minervini; A Zanollo; U Fontanella; R Giannoni; A Maggioni; E Lasio|
Related Documents :
|22640979 - N-acetylcysteine for the prevention of stricture after circumferential endoscopic submu...
22340549 - Safety and feasibility of repeated percutaneous transradial coronary intervention in th...
22679379 - Review of the southeast asian species of the aenictus javanus and aenictus philippinens...
18208889 - Factors predicting incomplete recovery from relapses in multiple sclerosis: a prospecti...
2646359 - The "natural history" of ulcerative colitis: an analysis of the placebo response.
22724059 - Evolution of in-group favoritism.
18478229 - Open resection of osteoid osteoma guided by a gamma-probe.
8436739 - Prophylactic versus standby cardiopulmonary support for high risk percutaneous translum...
22994669 - Adverse effects of intralesional meglumine antimoniate and its influence on clinical la...
|Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't|
|Title: European urology Volume: 9 ISSN: 0302-2838 ISO Abbreviation: Eur. Urol. Publication Date: 1983|
|Created Date: 1983-09-23 Completed Date: 1983-09-23 Revised Date: 2009-11-19|
Medline Journal Info:
|Nlm Unique ID: 7512719 Medline TA: Eur Urol Country: SWITZERLAND|
|Languages: eng Pagination: 202-6 Citation Subset: IM|
|APA/MLA Format Download EndNote Download BibTex|
Clinical Trials as Topic
Kidney Neoplasms / drug therapy, surgery, therapy*
Medroxyprogesterone / analogs & derivatives*, therapeutic use
Neoplasm Recurrence, Local
Receptors, Steroid / analysis
|0/Receptors, Steroid; 520-85-4/Medroxyprogesterone; 71-58-9/Medroxyprogesterone Acetate|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Studies on 18F-labeled pyrimidines. Tumor uptakes of 18F-5-fluorouracil, 18F-5-fluorouridine, and 18...
Next Document: Complete regression of multiple pulmonary metastases in a patient with advanced renal cell carcinoma...